Seldon Capital’s Idexx Laboratories IDXX Stock Holding History

Seldon Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-267	Closed	-$109K	–	140
2022 Q4	$109K	Hold	267	–	–	0.09%	72
2022 Q3	$87K	Hold	267	–	–	0.06%	82
2022 Q2	$94K	Hold	267	–	–	0.05%	88
2022 Q1	$146K	Hold	267	–	–	0.09%	70
2021 Q4	$176K	Buy	+267	New	+$168K	0.11%	67

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Seldon Capital's IDXX Position: Q1 2023 in Review

Seldon Capital sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 267 shares — an estimated $109K sold.

Seldon Capital first reported a position in IDXX in Q4 2021 and held it in 5 quarters. The position peaked at $176K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

Seldon Capital reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
Seldon Capital sold 267 Idexx Laboratories shares in Q1 2023, an estimated $109K.
Seldon Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 5 quarters.
Seldon Capital's Idexx Laboratories position peaked at $176K in Q4 2021.
1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.